Vaccine Shows Promise for Pancreatic Cancer, Study Finds
The mRNA vaccine works by targeting genetic mutations found in pancreatic cancer, alerting the immune system to recognize and ...
Vaccine targeting pancreatic cancer shows promise in new study of clinical trial
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
mRNA vaccines show promise against pancreatic cancer in early trial
Personalized mRNA vaccines show promise as a pancreatic cancer treatment, according to a small, early stage trial published ...
pancan2d
Research Spotlight
PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit offers insight into the new NCCN guidelines, discusses the new ...
Interesting Engineering on MSN2d
New mRNA vaccine shows promise against pancreatic cancer, may extend life by 10 years
Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.
Nature4d
Bespoke vaccines can elicit long-lived immune activity against pancreatic cancer
A multicentre randomized trial of bespoke RNA vaccines in pancreatic cancer (NCT05968326) is under way to further test this approach. • Cancers with few mutations, such as pancreatic cancer ...
Scientists identify epigenetic key that 'opens' door to colon cancer
A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...
Cardiff Oncology: Pioneering RAS-Mutated Cancer Therapies With Onvansertib
Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...